StockPriceToday
Cadence Design Systems Inc (CDNS)
About Cadence Design Systems Inc
Cadence Design Systems Inc. provides electronic design automation software, hardware, and services for designing integrated circuits and electronic systems worldwide. The company's essential role in semiconductor design has made CDNS stock price correlated with semiconductor industry innovation cycles and design complexity trends.
Cadence's software tools enable engineers to design, verify, and optimize complex semiconductor devices and electronic systems before manufacturing. The company's solutions are used by leading technology companies to create processors, memory devices, and system-on-chip products.
The company's intellectual property portfolio includes pre-designed circuit blocks that help customers accelerate product development while reducing design risks. Cadence's system design and verification tools address the growing complexity of modern electronic systems, positively influencing CDNS stock price performance.
Cadence's expansion into artificial intelligence, automotive, and aerospace applications demonstrates its commitment to supporting emerging technology markets. The company's ability to anticipate and address evolving design challenges while maintaining its market leadership position remains crucial for its long-term growth and success in the electronic design automation industry.
CDNS Stock 12 Month Chart
Latest News for CDNS
This was the stock's fourth consecutive day of losses.
Investors in Cadence Design Systems, Inc. CDNS need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2026 $220 Call had some of the highest ...
Cadence Design Systems (CDNS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Other Popular Stocks
Cintas Corporation provides specialized products and services including uniforms, mats, mops, restroom supplies, first aid and safety products, fire extinguishers, and training for businesses.
Pyxis Oncology Inc. (PYXS) is a clinical-stage biopharmaceutical company developing novel antibody-based therapeutics to treat cancer, focusing on antibody-drug conjugates and immuno-oncology approaches.
ArrowMark Financial Corp. operates as a business development company providing financing solutions to middle-market companies.